Centogene B V Company Overview
About Centogene B V
Centogene (NASDAQ: CNTG) is a multifaceted biotech company deeply rooted in the science of genetic and biochemical testing. The company focuses on transforming care for patients with rare diseases by leveraging its extensive data-driven understanding of molecular pathologies. Through its innovative diagnostic and research solutions, Centogene aims to accelerate the speed of discovering rare disease insights, thus facilitating more personalized patient care. It works on a global scale, collaborating with healthcare providers and pharmaceutical companies to enhance diagnostic accuracy and therapeutic developments. One of the main objectives of Centogene is to bridge critical gaps in rare disease treatment by translating complex genetic information into actionable clinical insights, ultimately aiming to improve patients' quality of life worldwide.
Snapshot
Operations
Products and/or services of Centogene B V
- CentoCard: A proprietary, CE-marked blood collection kit enabling efficient, globally accessible genetic testing.
- CentoMD: An exhaustive, mutation-centric genetic database designed for diagnosis acceleration and research facilitation.
- CentoGene's NGS Panels: Tailored next-generation sequencing panels for precise diagnosis across various genetic disorders.
- CentoPortal: A secure, intuitive online platform for data management, test ordering, and result interpretation.
- CentoCloud: A scalable, cloud-based solution for integrating genetic testing workflows into laboratory and clinical practices.
- Rare Disease Screening: Comprehensive screening solutions for early detection of rare genetic diseases.
Centogene B V executive team
- Dr. Andrin Oswald M.D., Ph.D.Advisor